StockMarketWire.com - AstraZeneca and Oxford University reportedly paused their Covid-19 vaccine study after a UK participant in the trial suffered a suspected serious adverse reaction, according to Stat News.
AstraZeneca, in a statement to Stat News, described the pause as a 'routine action' in the case of 'an unexplained illness.'
The company also said it would expedite the review to minimise any potential impact on the trial timeline.
At 8:00am: [LON:AZN] Astrazeneca PLC share price was 0p at 8348p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.